HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada, the...

Mar 15, 2025 · HLS Therapeutics Inc. (TSE:HLS - Get Free Report)'s share price dropped 1.2% during trading on Thursday . The company traded as low as C$3.92 and last traded at C$3.96. Approximately 27,905 shares changed hands during mid-day trading, an increase of 72% from the average daily volume of 16,203 shares. The stock had previously closed at C$4.01.

HLS provides access to medications critical to Health Care Providers, patients and their caregivers with the high-quality brand names they trust.

Mar 13, 2025 · HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), a pharmaceutical company focused on addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease ...

Mar 13, 2025 · HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), a pharmaceutical company focused on addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease,...

Mar 13, 2025 · HLS Therapeutics Inc. is a pharmaceutical company focused on the acquisition and commercialization of late-stage development, commercial stage promoted and established branded pharmaceutical products in the North American markets.

TORONTO, March 13, 2025 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), a pharmaceutical company focused on addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease, announces its financial results for the three and twelve months ended December 31, 2024.

TORONTO, March 13, 2025 /CNW/ - HLS Therapeutics Inc. (“HLS” or the “Company”) (TSX: HLS), a pharmaceutical company focused on addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease, announces that Christine Elliott has been appointed to the Company’s Board of Directors (the “Board”), effective ...

View contacts for HLS Therapeutics to access new leads and connect with decision-makers. HLS is dedicated to the stewardship of branded pharmaceuticals through their life cycles post - exclusivity. HLS ensures the availability of treatments critical to patients and their caregivers with the brand names they trust.

HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada,...